George Farmer
Stock Analyst at Scotiabank
(2.16)
# 2,611
Out of 4,762 analysts
67
Total ratings
37.14%
Success rate
-0.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $31.81 | +28.89% | 4 | Feb 28, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $70.54 | +13.41% | 8 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Sector Outperform | $244 → $224 | $140.19 | +59.78% | 3 | Feb 13, 2025 | |
| VKTX Viking Therapeutics | Initiates: Sector Outperform | $102 | $29.55 | +245.18% | 1 | Feb 13, 2025 | |
| SAGE Sage Therapeutics | Maintains: Sector Outperform | $14 → $12 | $7.69 | +56.05% | 5 | Feb 12, 2025 | |
| INMB INmune Bio | Maintains: Sector Outperform | $22 → $23 | $8.77 | +162.26% | 2 | Feb 11, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $18 → $16 | $13.12 | +21.95% | 3 | Jan 8, 2025 | |
| KURA Kura Oncology | Maintains: Sector Perform | $18 → $10 | $7.71 | +29.70% | 2 | Jan 8, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $35 → $47 | $23.36 | +101.20% | 3 | Dec 11, 2024 | |
| ARGX argenx SE | Upgrades: Sector Outperform | $439 → $715 | $591.45 | +20.89% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $7.49 | +207.08% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $2.78 | +619.42% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $21 → $41 | $2.46 | +1,566.67% | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $38.24 | +98.74% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $3.15 | $0.46 | +582.26% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $3.12 | +316.67% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $0.81 | +1,500.00% | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $66 | $72.72 | -9.24% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $35.02 | +211.25% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $67.73 | +28.45% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.19 | +1,406.85% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $1.15 | +3,378.26% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $37.20 | -27.42% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $90.50 | -17.13% | 3 | Apr 29, 2020 |
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $31.81
Upside: +28.89%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $70.54
Upside: +13.41%
Biogen
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $140.19
Upside: +59.78%
Viking Therapeutics
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $29.55
Upside: +245.18%
Sage Therapeutics
Feb 12, 2025
Maintains: Sector Outperform
Price Target: $14 → $12
Current: $7.69
Upside: +56.05%
INmune Bio
Feb 11, 2025
Maintains: Sector Outperform
Price Target: $22 → $23
Current: $8.77
Upside: +162.26%
Syndax Pharmaceuticals
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $16
Current: $13.12
Upside: +21.95%
Kura Oncology
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $7.71
Upside: +29.70%
NewAmsterdam Pharma Company
Dec 11, 2024
Maintains: Sector Outperform
Price Target: $35 → $47
Current: $23.36
Upside: +101.20%
argenx SE
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $591.45
Upside: +20.89%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $7.49
Upside: +207.08%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $2.78
Upside: +619.42%
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $2.46
Upside: +1,566.67%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $38.24
Upside: +98.74%
May 30, 2024
Initiates: Sector Outperform
Price Target: $3.15
Current: $0.46
Upside: +582.26%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.12
Upside: +316.67%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $0.81
Upside: +1,500.00%
Dec 19, 2023
Initiates: Sector Outperform
Price Target: $66
Current: $72.72
Upside: -9.24%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $35.02
Upside: +211.25%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $67.73
Upside: +28.45%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.19
Upside: +1,406.85%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $1.15
Upside: +3,378.26%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $37.20
Upside: -27.42%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $90.50
Upside: -17.13%